Search Results - Van Gennep, E.J.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer

    Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer by Voskuilen, C.S., Van Gennep, E.J., Vegt, E., Donswijk, M., Fransen Van De Putte, E.E., Van Der Poel, H.G., Horenblas, S., Van Rhijn, B.W.G., Hendricksen, K., Mertens, L.S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P261 A Phase 1b-2 study of chemoradiotherapy combined with Nivolumab and Ipilimumab as bladder sparing curative treatment for muscle Invasive bladder cancer: The CRIMI study

    P261 A Phase 1b-2 study of chemoradiotherapy combined with Nivolumab and Ipilimumab as bladder sparing curative treatment for muscle Invasive bladder cancer: The CRIMI study by Remmelink, M.J., Oddens, J.R., Nieuwenhuijzen, J.A., Daniels, L.A., Piet, A.H.M., Donker, M., Van Gennep, E.J., Van Der Hulle, T., Voortman, J., Bins, A.D.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The role of 18F-FDG-PET/CT for staging patients with high risk non-muscle invasive bladder cancer before radical cystectomy

    The role of 18F-FDG-PET/CT for staging patients with high risk non-muscle invasive bladder cancer before radical cystectomy by van Ginkel, N., Van Gennep, E.J., Boellaard, T.N., Wondergem, M., De Reijke, T.M., Vis, A.N., Van Rhijn, B.W.G., Mertens, L.S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: